Refine by
Nasal Swab Articles & Analysis: Older
18 news found
In cooperation with Brussels Airport, this nasal-swab ultra-fast PCR test, as well as the new breath sampler developed by imec and licensed by miDiagnostics, will be tested in practice during a study at the airport’s Test Centre. ...
(LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial. The trial is evaluating how effectively Ondine’s nasal photodisinfection technology eradicates pathogens – specifically Staphylococcus aureus – in the nose. ...
“Top-line results from this clinical trial suggest that nasal photodisinfection treatment rapidly and substantially suppresses SARS-CoV-2 viral replication and infectivity in the nasal cavity of already-vaccinated individuals. ...
The AscencioDx works by employing an easy and comfortable lower nasal swab sampling procedure and uses sophisticated multiplex viral RNA detection molecular diagnostic chemistry and hardware technology first developed at the University of Washington to detect and differentiate HIV viral variants. ...
HiberGene’s PCR Adapt COVID-19 RT-qPCR is a CE marked multi-target SARS-CoV-2 test for nasopharyngeal (NP), oropharyngeal (OP) and anterior nasal swabs. This single tube assay is validated for both direct sample testing and manual/automated extraction. ...
Together with the Agilent Bravo BenchCel DB liquid handling platform, the DETECTR BOOST® SARS-CoV-2 Reagent Kit detects SARS-CoV-2 RNA in nasopharyngeal, anterior nasal, mid-turbinate nasal or oropharyngeal swab specimens from individuals suspected of COVID-19 by their healthcare provider, and the test is performed in high complexity CLIA ...
The AscencioDx offers: Rapid test results equivalent to lab-based PCR tests Easy and comfortable lower nasal swab sampling procedure Positive test results in approximately 30 minutes Simple reporting process not requiring a complicated phone app or use of Bluetooth™ Price comparable to less accurate antigen tests and much lower than lab-based PCR ...
The test is compatible with both nasopharyngeal and the less invasive nasal swab sample collection and provides a simple “yes/no” result. ...
Unlike other testing methods, which require nasal swabs or saliva samples, wastewater testing can assess infection rates among a general population up to two weeks earlier than individual or pooled testing. ...
AZOVA Inc., creator of the world’s most comprehensive digital health network for COVID-19 testing and vaccination management, and Ellume, the company to bring the first non-prescription over-the-counter COVID-19 home test to market, today announced an official partnership with Alaska Airlines to provide a convenient, at-home rapid testing solution for its passengers. The Ellume COVID-19 ...
The increased sensitivity of this assay will empower researchers to sequence the complete genome and discover new variants from a variety of sample types including nasophyrengeal and shallow nasal swabs, saliva and others, and with cycle threshold (Ct) values higher than 28, or as low as 50 viral copies. ...
The TaqPath COVID-19, Flu A, Flu B Combo Kit is a real-time PCR test for the detection and differentiation of RNA from the SARS-CoV2, influenza A and influenza B viruses in nasopharyngeal and nasal swabs. "Understanding that the flu season would overlap with surges in COVID-19 infections, Thermo Fisher worked rapidly to develop a new multiplex real-time PCR ...
The test arrived in the mail in early November. I took it on a Wednesday, then mailed off my sample to Vienna for processing. On Friday, I received an email with a link to my results: negative. I didn’t have the symptoms anyway, apart from fatigue—a common symptom of having an early rising toddler—but given the fact that many carriers remain asymptomatic, it was good to confirm ...
It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection. ...
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens when determined by a healthcare provider to be appropriate based on results of a COVID-19 questionnaire. ...
In response to the rapid changes of the global pandemic and rising demand for self-testing with a gradual easing of border restrictions, iXensor launched its new product, PixoTest® COVID -19 Antigen Self-Test Kit as Simple (easy sampling by simple nasal swab) Fast (obtaining test results within 15 minutes) Reliable (up to 98% accuracy) ...
ByiXensor
Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, announced today that it has entered into a research collaboration with Janssen Pharmaceuticals, Inc., (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to advance Alveo’s be.well™ platform of analyzers, ...
Interested donors must have a diagnosis made with a test (nasal swab or blood) and complete resolution of COVID-19 symptoms at least 28 days prior to donation, or complete resolution of symptoms at least 14 days prior to donation along with a negative molecular test for COVID-19, as well as meet our routine eligibility criteria for normal source plasma ...